WLKP
Westlake Chemical Partners LP NYSE Listed Jul 30, 2014$23.23
Mkt Cap $818.8M
52w Low $17.75
93.7% of range
52w High $23.60
50d MA $22.37
200d MA $21.00
P/E (TTM)
2.7x
EV/EBITDA
2.3x
P/B
1.0x
Debt/Equity
0.8x
ROE
115.5%
P/FCF
3.3x
RSI (14)
—
ATR (14)
—
Beta
0.55
50d MA
$22.37
200d MA
$21.00
Avg Volume
39.3K
Westlake Chemical Partners LP acquires, develops, and operates ethylene production facilities and related assets in the United States. The company's ethylene production facilities primarily convert ethane into ethylene. It also sells ethylene co-products, including propylene, crude butadiene, pyrolysis gasoline, and hydrogen directly to third parties on either a spot or contract basis. Westlake Chemical Partners GP LLC serves as the general partner of the company. The company was incorporated in 2014 and is headquartered in Houston, Texas.
2801 Post Oak Boulevard · Houston, TX 77056 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 24, 2026 | BMO | 0.38 | 0.41 | +8.2% | 21.24 | +0.6% | +4.0% | -0.3% | -0.7% | +0.7% | +0.8% | — |
| Oct 30, 2025 | BMO | 0.43 | 0.42 | -2.3% | 18.95 | +0.1% | +0.0% | -0.5% | -1.0% | -0.9% | +0.9% | — |
| Aug 5, 2025 | BMO | 0.44 | 0.41 | -7.7% | 21.80 | +0.0% | +1.0% | -0.4% | +0.2% | -0.0% | +1.7% | — |
| May 2, 2025 | BMO | 0.38 | 0.14 | -63.2% | 23.80 | -4.2% | -2.2% | -0.5% | -0.6% | +0.2% | +0.6% | — |
| Feb 24, 2025 | BMO | 0.36 | 0.43 | +19.4% | 24.22 | +1.0% | +0.8% | -0.9% | -0.6% | -0.3% | +0.1% | — |
| Nov 5, 2024 | BMO | 0.40 | 0.51 | +27.5% | 22.46 | +1.3% | -0.0% | -0.6% | +0.9% | +0.5% | +1.6% | — |
| Aug 6, 2024 | BMO | 0.44 | 0.41 | -6.8% | 22.70 | +0.4% | +1.3% | -1.3% | +0.5% | +0.6% | -2.0% | — |
| May 1, 2024 | BMO | 0.45 | 0.42 | -6.7% | 21.86 | +0.2% | +0.5% | +2.3% | -1.6% | +1.3% | -1.5% | — |
| Feb 20, 2024 | BMO | 0.45 | 0.41 | -8.9% | 22.31 | +0.9% | -1.7% | +0.0% | +3.1% | -1.1% | +1.4% | — |
| Nov 2, 2023 | BMO | 0.44 | 0.37 | -15.9% | 22.03 | -2.6% | +3.2% | -3.3% | +0.1% | -1.4% | +0.8% | — |
| Aug 3, 2023 | BMO | 0.38 | 0.34 | -10.5% | 22.82 | -0.1% | +1.1% | -0.5% | +0.4% | -0.2% | +0.0% | — |
| May 4, 2023 | BMO | 0.47 | 0.42 | -10.6% | 21.84 | -1.6% | -2.9% | +2.4% | +0.1% | -0.8% | +0.2% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 30 | Deutsche Bank | Maintains | Buy → Buy | — | $21.29 | $21.29 | +0.0% | +0.6% | +0.4% | +3.3% | -0.7% | -0.0% |
| May 22 | Deutsche Bank | Maintains | Buy → Buy | — | $21.61 | $21.71 | +0.5% | -0.6% | +0.3% | -0.8% | +0.2% | -0.5% |
| Feb 23 | Deutsche Bank | Maintains | Buy → Buy | — | $23.27 | $23.49 | +0.9% | +0.5% | +0.5% | +0.3% | -2.6% | -0.7% |
| Nov 18 | Deutsche Bank | Maintains | Buy → Buy | — | $22.56 | $22.26 | -1.3% | -0.1% | -0.5% | +0.3% | +0.5% | +0.3% |
| May 16 | Deutsche Bank | Maintains | Buy → Buy | — | $26.74 | $26.57 | -0.6% | +2.4% | +1.6% | -1.0% | -4.2% | -2.0% |
| May 9 | Barclays | Maintains | Overweight → Overweight | — | $27.93 | $28.10 | +0.6% | -2.1% | -0.7% | -2.3% | -2.5% | +3.4% |
| Mar 2 | Deutsche Bank | Maintains | Buy → Buy | — | $26.02 | $26.29 | +1.0% | +0.9% | -0.3% | +0.2% | -0.2% | +0.8% |
| May 5 | Deutsche Bank | Maintains | Buy → Buy | — | $27.00 | $27.19 | +0.7% | +0.5% | -0.1% | -0.0% | +0.9% | -0.5% |
| Mar 18 | UBS | Downgrade | Buy → Neutral | — | $24.72 | $24.40 | -1.3% | -0.8% | -0.4% | -0.7% | -2.8% | +1.9% |
| Feb 24 | Deutsche Bank | Maintains | Buy → Buy | — | $23.23 | $23.55 | +1.4% | +3.7% | +0.4% | -2.8% | -0.3% | +0.5% |
| Aug 20 | Tudor Pickering | Upgrade | Sell → Hold | — | $20.34 | $20.49 | +0.7% | +3.6% | -0.5% | +0.7% | -1.6% | -0.2% |
| May 5 | Citigroup | Maintains | Neutral → Neutral | — | $18.95 | $19.09 | +0.7% | -0.3% | -0.8% | +1.1% | +1.6% | -1.0% |
| May 5 | Deutsche Bank | Maintains | Buy → Buy | — | $18.95 | $19.09 | +0.7% | -0.3% | -0.8% | +1.1% | +1.6% | -1.0% |
| Oct 9 | Citigroup | Downgrade | Buy → Neutral | — | $22.87 | $22.45 | -1.8% | -0.0% | +1.2% | +0.3% | -0.3% | +0.9% |
| Oct 9 | Citi | Downgrade | Buy → Neutral | — | $22.87 | $22.45 | -1.8% | -0.0% | +1.2% | +0.3% | -0.3% | +0.9% |
| Sep 13 | Barclays | Upgrade | Equal Weight → Overweight | — | $21.72 | $22.25 | +2.4% | +1.6% | +2.1% | -0.3% | -0.4% | +0.3% |
| Jun 21 | Bernstein | Maintains | Market Perform → Perform | — | $24.85 | $24.95 | +0.4% | -1.2% | +0.6% | -0.6% | -0.2% | -0.4% |
| Mar 2 | UBS | Maintains | Buy → Buy | — | $22.85 | $22.85 | +0.0% | +0.0% | +1.1% | +0.6% | -0.9% | -0.9% |
| Dec 20 | Barclays | Maintains | Equal Weight → Equal Weight | — | $23.80 | $23.80 | +0.0% | -0.6% | -0.4% | -0.2% | -0.2% | +0.6% |
| Dec 5 | Citigroup | Maintains | Buy → Buy | — | $22.15 | $22.40 | +1.1% | +1.1% | +0.4% | +0.7% | +0.7% | +2.0% |
| Sep 9 | FBR Capital | Maintains | Outperform → Outperform | — | $22.96 | $23.19 | +1.0% | +2.7% | -0.5% | -1.2% | +2.0% | -1.8% |
| Feb 25 | Deutsche Bank | Maintains | Buy → Buy | — | $16.49 | $16.65 | +1.0% | -0.6% | +4.9% | -2.8% | +2.5% | +2.7% |
| Feb 24 | Barclays | Maintains | Equal Weight → Equal Weight | — | $16.64 | $16.50 | -0.8% | -0.9% | -0.6% | +4.9% | -2.8% | +2.5% |
| Aug 5 | Barclays | Maintains | Equal Weight → Equal Weight | — | $21.11 | $21.00 | -0.5% | -0.5% | -1.6% | +0.4% | -0.9% | -2.7% |
| Sep 8 | Wells Fargo | Maintains | Market Perform → Perform | — | $33.36 | $33.19 | -0.5% | -2.6% | -0.3% | -0.5% | +0.2% | -1.2% |
| Sep 8 | Bank of America | Maintains | Neutral → Neutral | — | $33.36 | $33.19 | -0.5% | -2.6% | -0.3% | -0.5% | +0.2% | -1.2% |
| Sep 8 | UBS | Maintains | Buy → Buy | — | $33.36 | $33.19 | -0.5% | -2.6% | -0.3% | -0.5% | +0.2% | -1.2% |
| Sep 8 | Deutsche Bank | Maintains | Buy → Buy | — | $33.36 | $33.19 | -0.5% | -2.6% | -0.3% | -0.5% | +0.2% | -1.2% |
| Sep 8 | Barclays | Maintains | Equal Weight → Equal Weight | — | $33.36 | $33.19 | -0.5% | -2.6% | -0.3% | -0.5% | +0.2% | -1.2% |
No insider trades available.
8-K
Westlake Chemical Partners LP -- 8-K Filing
Westlake Chemical Partners LP declared its 47th consecutive quarterly distribution of $0.4714 per unit, demonstrating consistent cash returns to investors amid ongoing operational performance.
May 5
8-K
Westlake Corporation -- 8-K Filing
Westlake Corporation appointed a new Chief Financial Officer with significant investment banking experience from Goldman Sachs, bringing enhanced financial expertise to the company's leadership team.
Apr 20
8-K
WESTLAKE CHEMICAL PARTNERS LP -- 8-K Filing
Westlake Chemical Partners LP appointed a CFO with extensive financial leadership experience, including prior roles at Valaris Limited and Goldman Sachs, strengthening the partnership's financial management capabilities.
Apr 20
8-K
WESTLAKE CHEMICAL PARTNERS LP -- 8-K Filing
Westlake Chemical Partners' fourth-quarter 2025 operating cash flow declined 9% year-over-year to $120.4 million, signaling softer operational performance for the energy infrastructure partnership.
Feb 24
8-K
WESTLAKE CHEMICAL PARTNERS LP -- 8-K Filing
I cannot provide a meaningful one-sentence analysis based on this filing summary, as it contains only technical XBRL metadata and reference information rather than substantive business developments or financial events affecting Westlake Chemical Partners LP investors.
Feb 23
Data updated apr 27, 2026 9:34am
· Source: massive.com